Phibro Animal Health | PAHC - 贸易债权人

金融业

USD

USD 1.45B

现金及等价物

USD 54.93M

USD 240.42M

USD 894.07M

USD 281.87M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 361.83M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 597.69M

USD 1.29B

USD 27.46M

USD 361.83M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 539.7M

贸易债权人

USD 129.64M

应收帐款人

USD 215.87M

	贸易债权人	更改		日
Align Technology	USD 123.72M		2.27M	2026-03
ANI Pharmaceuticals	USD 69.69M		7.11M	2026-03
Aurora Cannabis	CAD 68.03M		18.68M	2025-12
Bristol-Myers Squibb	USD 4.23B		659M	2026-03
Canopy Growth	CAD 19.96M		1.83M	2025-12
Corcept Therapeutics	USD 33.31M		7.14M	2026-03
Eli Lilly	USD 5.03B		350M	2026-03
Henry Schein	USD 1.04B		111M	2026-03
Idexx Laboratories	USD 129.97M		19.57M	2026-03
Knight Therapeutics	CAD 125.76M		7.63M	2025-12
Merck	USD 3.86B		541M	2026-03
Nektar Therapeutics	USD 10.77M		4.79M	2025-12
Pacira	USD 14.01M		1.14M	2026-03
Phibro Animal Health	USD 129.64M		3.65M	2026-03
Prestige Brands	USD 22.79M		20.15M	2026-03
Supernus Pharmaceuticals	USD 10.17M		97.63M	2026-03
Zoetis	USD 507M		20M	2026-03